{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T23:55:29Z","timestamp":1783641329058,"version":"3.55.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.vaccine.2015.12.029","type":"journal-article","created":{"date-parts":[[2015,12,22]],"date-time":"2015-12-22T05:20:15Z","timestamp":1450761615000},"page":"650-655","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Tick-borne encephalitis (TBE) vaccine to medically immunosuppressed patients with rheumatoid arthritis: A prospective, open-label, multi-centre study"],"prefix":"10.1016","volume":"34","author":[{"given":"Katarina Brodin","family":"Hertzell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karlis","family":"Pauksens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Rombo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Knight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirkka","family":"Vene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena H.","family":"Askling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Sep (38)","key":"10.1016\/j.vaccine.2015.12.029_bib0175","doi-asserted-by":"crossref","first-page":"4962","DOI":"10.1016\/j.vaccine.2015.07.030","article-title":"Tick borne encephalitis (TBE)-vaccination coverage and analysis of variables associated with vaccination, Sweden","volume":"33","author":"Askling","year":"2015","journal-title":"Vaccine."},{"issue":"Apr (Suppl. 1)","key":"10.1016\/j.vaccine.2015.12.029_bib0180","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/S0264-410X(02)00811-3","article-title":"Tick-borne encephalitis\u2014pathogenesis, clinical course and long-term follow-up","volume":"21","author":"Haglund","year":"2003","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2015.12.029_bib0185","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1080\/00365540310005305","article-title":"Tick-borne encephalitis: a retrospective study of clinicalcases in Bornholm, Denmark","volume":"35","author":"Laursen","year":"2003","journal-title":"Scand J Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2015.12.029_bib0190","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1586\/erv.12.86","article-title":"Vaccines and vaccination against tick-borne encephalitis","volume":"11","author":"Kollaritsch","year":"2012","journal-title":"Expert Rev Vaccines"},{"issue":"16","key":"10.1016\/j.vaccine.2015.12.029_bib0195","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1016\/j.vaccine.2010.02.001","article-title":"Vaccine failures after active immunisation against tick-borne encephalitis","volume":"28","author":"Andersson","year":"2010","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2015.12.029_bib0200","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1002\/art.10524","article-title":"Frequency of infection in patients with rheumatoid arthritis compared with controls","volume":"46","author":"Doran","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.vaccine.2015.12.029_bib0205","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/rheumatology\/kel366","article-title":"Influenza vaccination as model for testing immune modulation induced by anti-TNF and methotrexate therapy in rheumatoid arthritis patients","volume":"46","author":"Kapetanovic","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.vaccine.2015.12.029_bib0210","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1136\/ard.2007.077552","article-title":"The effect of anti-tumour necrosis factor alpha treatment on the antibody response to influenza vaccination","volume":"67","author":"Gelinck","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.vaccine.2015.12.029_bib0215","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1136\/gutjnl-2011-300256","article-title":"Serological response to the 2009 H1N1 influenza vaccination in patients with inflammatory bowel disease","volume":"61","author":"Cullen","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.vaccine.2015.12.029_bib0220","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1136\/gut.2010.233981","article-title":"European Crohn's and Colitis Organisation (ECCO), H1N1 vaccines in a large observational cohort of patients with inflammatory bowel disease treated with immunomodulators and biological therapy","volume":"60","author":"Rahier","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.vaccine.2015.12.029_bib0225","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/ajg.2009.523","article-title":"Immunosuppression impairs response to pneumococcal polysaccharide vaccination in patients with inflammatory bowel disease","volume":"105","author":"Melmed","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.vaccine.2015.12.029_bib0230","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1002\/ibd.21800","article-title":"Effects of immunosuppression on immune response to pneumococcal vaccine in inflammatory bowel disease: a prospective study","volume":"18","author":"Fiorino","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.vaccine.2015.12.029_bib0235","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.1002\/art.30580","article-title":"Antibody response is reduced following vaccination with 7-valent conjugate pneumococcal vaccine in adult methotrexate-treated patients with established arthritis, but not those treated with tumor necrosis factor inhibitors","volume":"63","author":"Kapetanovic","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.vaccine.2015.12.029_bib0240","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1053\/j.semarthrit.2003.10.003","article-title":"The effect of tumor necrosis factor blockade on the response to pneumococcal vaccination in patients with rheumatoid arthritis and ankylosing spondylitis","volume":"33","author":"Elkayam","year":"2004","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.vaccine.2015.12.029_bib0245","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/rheumatology\/kei193","article-title":"Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis","volume":"45","author":"Kapetanovic","year":"2006","journal-title":"Rheumatology"},{"key":"10.1016\/j.vaccine.2015.12.029_bib0250","first-page":"272","article-title":"Immune responses following administration of influenza and pneumococcal vaccines to patients with rheumatoid arthritis receiving adalimumab","volume":"34","author":"Kaine","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.vaccine.2015.12.029_bib0255","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1136\/ard.2005.036434","article-title":"Vaccination against influenza in rheumatoid arthritis: the effect of disease modifying drugs, including TNF alpha blockers","volume":"65","author":"Fomin","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.vaccine.2015.12.029_bib0260","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1136\/ard.2007.077461","article-title":"Vaccination against influenza in patients with rheumatoid arthritis: the effect of rituximab on the humoral response","volume":"67","author":"Oren","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.vaccine.2015.12.029_bib0265","doi-asserted-by":"crossref","first-page":"R209","DOI":"10.1186\/ar3542","article-title":"Decreased influenza-specific B cell responses in rheumatoid arthritis patients treated with anti-tumor necrosis factor","volume":"13","author":"Kobie","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.vaccine.2015.12.029_bib0270","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1136\/annrheumdis-2012-201950","article-title":"Impact of tocilizumab therapy on antibody response to influenza vaccine in patients with rheumatoid arthritis","volume":"71","author":"Mori","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.vaccine.2015.12.029_bib0275","first-page":"1356","article-title":"Pneumococcal vaccine response in psoriatic arthritis patients during treatment with etanercept","volume":"31","author":"Mease","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.vaccine.2015.12.029_bib0280","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1086\/598193","article-title":"Randomized, double-blind comparative trial of subunit and virosomal influenza vaccines for immunocompromised patients","volume":"48","author":"Evison","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2015.12.029_bib0285","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.1016\/j.vaccine.2008.04.028","article-title":"Synergistic immunosuppressive effect of anti-TNF combined with methotrexate on antibody responses to the 23 valent pneumococcal polysaccharide vaccine","volume":"26","author":"Gelinck","year":"2008","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2015.12.029_bib0290","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.tmaid.2014.01.005","article-title":"Hepatitis A vaccine for immunosuppressed patients with rheumatoid arthritis: a prospective, open-label, multi-centre study","volume":"12","author":"Askling","year":"2014","journal-title":"Travel Med Infect Dis"},{"issue":"20","key":"10.1016\/j.vaccine.2015.12.029_bib0295","doi-asserted-by":"crossref","first-page":"3511","DOI":"10.1016\/j.vaccine.2010.03.024","article-title":"Decreased antibody titers and booster responses in tick-borne encephalitis vaccinees aged 50\u201390 years","volume":"28","author":"Weinberger","year":"2010","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2015.12.029_bib0300","doi-asserted-by":"crossref","first-page":"e100860","DOI":"10.1371\/journal.pone.0100860","article-title":"Factors determining immunological response to vaccination against tick-borne encephalitis virus in older individuals","volume":"9","author":"Lindblom","year":"2014","journal-title":"PLoS ONE"},{"issue":"7","key":"10.1016\/j.vaccine.2015.12.029_bib0305","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1517\/14712590903066711","article-title":"Serological response to tick-borne encephalitis (TBE) vaccination in the elderly\u2014results from an observational study","volume":"9","author":"J\u00edlkov\u00e1","year":"2009","journal-title":"Expert Opin Biol Ther"},{"issue":"25","key":"10.1016\/j.vaccine.2015.12.029_bib0310","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1016\/j.vaccine.2005.01.085","article-title":"Insufficient protection for healthy elderly adults by tetanus and TBE vaccines","volume":"23","author":"Hainz","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.12.029_bib0315","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1756-3305-5-8","article-title":"Changes in the geographical distribution and abundance of the tick Ixodes ricinus during the past 30 years in Sweden","volume":"5","author":"Jaenson","year":"2012","journal-title":"Parasit Vectors"},{"issue":"2","key":"10.1016\/j.vaccine.2015.12.029_bib0320","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.vaccine.2006.07.026","article-title":"Study of the serological response after vaccination against tick-borne encephalitis in Sweden","volume":"25","author":"Vene","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.12.029_bib0325","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0166-0934(98)00041-X","article-title":"A rapid fluorescent focus inhibition test (RFFIT) for detection of neutralizing antibodies to tick-borne encephalitis (TBE) virus","volume":"73","author":"Vene","year":"1998","journal-title":"J Virol Methods"},{"issue":"3","key":"10.1016\/j.vaccine.2015.12.029_bib0330","doi-asserted-by":"crossref","first-page":"e34145","DOI":"10.1371\/journal.pone.0034145","article-title":"Age affects quantity but not quality of antibody responses after vaccination with an inactivated flavivirus vaccine against tick-borne encephalitis","volume":"7","author":"Stiasny","year":"2012","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.vaccine.2015.12.029_bib0335","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1586\/14760584.5.4.461","article-title":"Are tick-borne encephalitis vaccines interchangeable?","volume":"5","author":"Br\u00f6ker","year":"2006","journal-title":"Expert Rev Vaccines"},{"issue":"3","key":"10.1016\/j.vaccine.2015.12.029_bib0340","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.vaccine.2011.11.061","article-title":"Immunogenicity of delayed TBE-vaccine booster","volume":"30","author":"Askling","year":"2012","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15018204?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15018204?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,16]],"date-time":"2018-09-16T13:58:51Z","timestamp":1537106331000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15018204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S0264410X15018204"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.12.029","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tick-borne encephalitis (TBE) vaccine to medically immunosuppressed patients with rheumatoid arthritis: A prospective, open-label, multi-centre study","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.12.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}